SciELO - Scientific Electronic Library Online

vol.50 número2Hipodermoclisis en pacientes con cáncer terminalUso de riñones para trasplante renal provenientes de donantes de 55 o más años índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados



  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO


Revista Cubana de Medicina

versión On-line ISSN 1561-302X


CHAVEZ MEDINA, Reysel et al. Clinical features and therapeutic results of primary mediastinal large B- cells non-Hodgkin's lymphomas. Rev cubana med [online]. 2011, vol.50, n.2, pp. 157-166. ISSN 1561-302X.

A retrospective, descriptive and observational study was conducted to assess the clinical-biological features and the therapeutic results of the primary mediastinal of large B cells lymphoma in 34 patients seen in the "Hermanos Ameijeiras" Clinical Surgical Hospital from June, 1989 to February, 2009. There was predominance of female sex (61.8 %), mean age of 31.5 years (19 to 61 years) and of white race (70.6 %). The localized stages were more frequent (67.7 %), without B symptoms (64.7 %) and with a large tumor mass (70.6 %). Global survival and the free of progression survival at five years were of 53.4 and 43.4 %, respectively. The global survival at three years of the patients treated with MACOPB/VACOPB, CHOP and R-CHOP was of 77.7; 30.4 and 100 %, respectively. It was proved that patients treated with MACOPB/VACOPB had better results than those treated with CHOP. Age-adjusted international prognostic rate was not a survival predictor. In multivariable analysis, the only survival predictor was the applied (CHOP versus MACOPB). The routine use of radiotherapy has neither a significant impact on the global survival nor on the free of progression survival at five years.

Palabras clave : No-Hodgkin primary mediastinal large B cells lymphoma.

        · resumen en Español     · texto en Español     · Español ( pdf )


Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License